Compare MGTX & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | SBGI |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 909.8M |
| IPO Year | 2018 | 2023 |
| Metric | MGTX | SBGI |
|---|---|---|
| Price | $9.22 | $12.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | ★ $27.75 | $17.57 |
| AVG Volume (30 Days) | ★ 819.2K | 443.1K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 8.07% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | $81,391,000.00 | ★ $3,169,000,000.00 |
| Revenue This Year | $314.19 | $11.11 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.09 | ★ N/A |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $12.23 |
| 52 Week High | $15.35 | $17.88 |
| Indicator | MGTX | SBGI |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 38.23 |
| Support Level | $8.84 | N/A |
| Resistance Level | $10.06 | $14.50 |
| Average True Range (ATR) | 0.52 | 0.46 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 6.12 | 6.57 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay TV distributors.